MGMT promoter methylation status—information gathered at a DNA-level—can help predict overall survival for patients with a rare form of brain cancer known as anaplastic astrocytoma, according to a new analysis from The ...
Sep 26, 2017
0
2
NRG Oncology researchers recently developed and validated a nomogram that can predict 2-year and 5-year overall survival (OS) and progression-free survival (PFS) for patients with local-regionally advanced oropharyngeal squamous ...
Aug 21, 2017
0
0
Insurance companies end up covering proton therapy treatment for pediatric cancer patients in 97 percent of the cases they originally deny once those decisions are appealed. Researchers from the Perelman School of Medicine ...
Aug 7, 2017
0
0
(HealthDay)—High intake of total and saturated fat is associated with increased risk of lung cancer, according to research published online July 25 in the Journal of Clinical Oncology.
Jul 28, 2017
0
1
(HealthDay)—New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money ...
Jul 19, 2017
0
0
Today, a new drug will become available for patients with bowel cancer as part of a national clinical trial; based on a scientific discovery made only two years ago at the CRUK/MRC Oxford Institute for Radiation Oncology.
Jun 30, 2017
0
2
(HealthDay)—For development of oncology drugs in Japan, the global trial (GT) strategy and early-initiation bridging (BG) strategy are associated with shorter submission lag (SL) than late-initiation BG strategy, according ...
Jun 21, 2017
0
1
Androgen drives many prostate cancers. But the body uses androgen for muscle growth and maintenance, among other functions. An ongoing study published in the Journal of Clinical Oncology along with the American Society for ...
Jun 5, 2017
0
1
Six years ago an international team of physician scientists known as BRCA-TAC led a charge to advance clinical testing of the PARP inhibitor olaparib in cancer patients with known inherited mutations in BRCA1 and BRCA2. This ...
Jun 4, 2017
0
0
An Ontario-led international clinical trial with 1,206 men with localized prostate cancer shows that compressing radiation treatments into four weeks from eight delivers similar outcomes.
Mar 16, 2017
0
0
